Neurovascular Devices Companies

The global neurovascular devices market is projected to reach USD 7.22 billion in 2030 from USD 4.64 billion in 2025, at a CAGR of 9.3% during the forecast period.

Several factors influence the neurovascular devices market. The two most significant ones are the rising incidence of neurovascular diseases and the expansion of healthcare infrastructure across emerging economies, which are key drivers for the neurovascular devices market. The increasing prevalence of conditions such as stroke, cerebral aneurysms, and arteriovenous malformations is largely due to aging populations, sedentary lifestyles, poor dietary habits, rising rates of hypertension and diabetes, and increased exposure to risk factors like smoking and alcohol consumption. As these diseases often require urgent and specialized interventions, the demand for advanced neurovascular devices such as thrombectomy systems, embolization coils, and flow diverters continues to grow.

Certain challenges may, however, impede market expansion. The high procedural costs of neurovascular surgeries and related products pose a major barrier, as many patients—especially in low- and middle-income regions—cannot afford advanced technologies. Additionally, stringent regulatory approval processes for medical devices further slowdown the market penetration.

Prominent players in the global neurovascular device market include. Stryker (US), Johnson & Johnson (US), Medtronic (Ireland), Terumo Corporation (Japan), and Penumbra (US).

To know about the assumptions considered for the study download the pdf brochure

Key players in the neurovascular devices market have adopted a combination of organic and inorganic growth strategies—such as product launches, acquisitions, collaborations, partnerships, agreements, and expansions—to strengthen their global presence and increase market share. These efforts have allowed them to expand geographically and deliver neurovascular devices across diverse regions.

In July 2025, Stryker (US) announced the commercial launch of its next generation Surpass Elite Flow Diverter in the United States, South Korea, and Europe.

In June 2024, Medtronic launched the Artisse™ intrasaccular device in Europe for the treatment of intracranial aneurysms.

Stryker (US) is a leading global player in the neurovascular devices market, known for its strong product innovation and deep clinical expertise. The company operates through two main business segments—MedSurg and Neurotechnology and Orthopaedics—with its Neurovascular division being a key part of the MedSurg and Neurotechnology segment. Stryker’s neurovascular and neurosurgical product range includes advanced guidewires, microcatheters, balloon catheters, and detachable coils, all designed to support complex cerebrovascular procedures and enhance patient care outcomes.

In line with its commitment to advancing neurointervention, Stryker has formed a strategic partnership with Siemens Healthineers to develop a pioneering robotic system for neurovascular procedures. This collaboration combines Siemens’ expertise in imaging and robotics with Stryker’s leadership in neurovascular technologies to improve procedural accuracy, enhance aneurysm treatment, and increase access to timely, image-guided stroke care.

Johnson & Johnson (US) is a leading global player in the neurovascular devices market, supported by its strong history in healthcare innovation and widespread international presence. The company focuses on comprehensive R&D, manufacturing, and marketing of healthcare products in two main segments—Innovative Medicine and MedTech. In the MedTech division, Johnson & Johnson offers a broad range of solutions across Cardiovascular, Orthopaedics, Surgery, and Vision categories. Through its dedicated subsidiary Cerenovus, it provides an advanced portfolio of neurovascular devices, including occlusion balloon catheters, embolic coils, guidewires, liquid embolic systems, guiding catheters, and peripheral vascular products, all designed to support the treatment of ischemic and hemorrhagic strokes. With over 138,000 employees worldwide and operations in more than 60 countries, Johnson & Johnson utilizes its extensive resources, culture of innovation, and trusted brand reputation to reinforce its leadership in neurovascular care and enhance patient outcomes worldwide.

Medtronic (Ireland) controlled a significant share of the neurovascular device market in 2024. As a global leader in medical technology since 1949, Medtronic has been at the forefront of health innovation. Headquartered in Dublin, Ireland, the company’s mission is to relieve pain, restore health, and extend life. With operations in over 150 countries and more than 95,000 employees, it ranks among the world’s largest medical tech companies. Medtronic divides its extensive portfolio into four main divisions: Cardiovascular, Diabetes, Medical Surgical, and Neuroscience, reinforcing its reputation as a trusted industry leader. The company launched the Neurovascular Co-Lab™ Platform, a virtual collaboration space designed to speed up innovation in stroke care and treatment. This platform connects clinicians, startups, and researchers with Medtronic’s expertise and resources, fostering the development of next-generation neurovascular solutions and enhancing its position as a leader in the global stroke care market.

MARKET RANKING

In the global neurovascular devices market, the competitive landscape is shaped by a mix of leading multinational corporations and strong regional players. Stryker (US) holds a leading position, driven by its broad product portfolio, global distribution network, and trusted brand legacy. The company has maintained its leadership through continuous product innovation and customer-focused marketing. Johnson & Johnson (US) is another major player, especially in North America and international markets. Medtronic (Ireland) also holds a significant share, with a variety of products it offers. Other notable companies include Terumo Corporation (Japan) and Penumbra (US), which contribute to market diversity through differentiated formulations and expansive retail reach. Collectively, these players dominate the neurovascular devices landscape, setting industry standards in formulation science, consumer trust, and global influence reach.

Related Reports:

Neurovascular Devices Market by Disease Pathology (Cerebral Aneurysm (Embolic coils, Flow Diverters), Ischemic Stroke (Clot Retriever, Aspiration, Snare), Carotid Stenosis (Stent, Embolic Protection), Others), End User (Hospitals) - Global Forecast to 2030